MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001: Shanghai Saturday, February 28, 2026, 18:00 Hrs [IST] MindRank, a cli ...
Arab nations face a very hot future, more severe heatwaves will continue for 1,000 years after we reach net zero, and changing land use has contributed to global warming, now global warming is ...